REG - GSK Capital B.V. - Annual Financial Report & Accounts 2024

GSKAnnouncement

Yesterday 16:45

For best results when printing this announcement, please click on link below:
https://newsfile.refinitiv.com/getnewsfile/v1/story?guid=urn:newsml:reuters.com:20250627:nRSa8231Oa&default-theme=true

RNS Number : 8231O  GSK Capital B.V.  27 June 2025

Issued: 27 June 2025, London UK

 

GSK Capital B.V. publication of 2024 Annual Report & Financial Statements

 

 

 

 

 

Today, 27 June 2025, GSK Capital B.V. (the "Company") published on the GSK
Group ("GSK") website, www.gsk.com*, its Annual Report and Financial
Statements in respect of the year ended 31 December 2024.

 

In compliance with Listing Rule 9.6.1 of the UK Financial Conduct Authority
("FCA"), copies of the Company's 2024 Annual Report and Financial Statements,
have been submitted to the FCA's National Storage Mechanism (NSM) submission
portal via Electronic Submission System (ESS). The Company is using the
exemption available to it under the Disclosure and Transparency Rules
6.3.5(1A) and is not setting out the full text of the regulated information in
this announcement and has instead made the regulated information available in
unedited full text on the NSM.

 

A copy can be viewed at
https://data.fca.org.uk/#/nsm/nationalstoragemechanism.

 

V A Whyte

GSK plc Company Secretary

27 June 2025

 

*
https://www.gsk.com/en-gb/company/codes-standards-and-reports/#gsk-capital-plc-annual-reports

 

Cautionary statement regarding forward-looking statements

GSK cautions investors that any forward-looking statements or projections made
by GSK, including those made in this announcement, are subject to risks and
uncertainties that may cause actual results to differ materially from those
projected. Such factors include, but are not limited to, those described in
the "Risk Factors" section in GSK's Annual Report on Form 20-F for 2024, and
GSK's Q1 Results for 2025.

 

Registered in England & Wales:

No. FC038264

      BR023357

 

UK establishment office address:

79 New Oxford Street

London

WC1A 1DG

 

 

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact
rns@lseg.com (mailto:rns@lseg.com)
 or visit
www.rns.com (http://www.rns.com/)
.

RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our
Privacy Policy (https://www.lseg.com/privacy-and-cookie-policy)
.   END  ACSZDLFLEQLLBBD